IP

InHarv Partners

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

InHarv Partners is an investment Firm.

Investor Profile

InHarv Partners has made 2 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does InHarv Partners frequently co-invest with?

The Mark Foundation for Cancer Research
North America, New York, United States, New York
Co-Investments: 1
Yonghua Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
20/20 HealthCare Partners
North America, Massachusetts, United States, Auburndale
Co-Investments: 1
3SBio Inc.
Asia, Liaoning, China, Shenyang
Co-Investments: 1
Highlight Capital
Asia, Jiangsu, China, Nanjin
Co-Investments: 1
LabCorp Venture Fund
North America, North Carolina, United States, Burlington
Co-Investments: 1

What are some of recent deals done by InHarv Partners?

Presage Biosciences

Seattle, Washington, United States

Presage Biosciences develops a technology platform to improve the cancer drug development process.

BiotechnologyHealth CareMedical
Series UnknownMar 2, 2021
Amount Raised: $7,000,000
Verseau Therapeutics

Bedford, Massachusetts, United States

Verseau focus is building a pipeline of first-in-class therapies that modulate macrophages to trigger a coordinated immune attack on cancer.

BiotechnologyTherapeutics
Series UnknownOct 21, 2019
Amount Raised: $50,000,000